Stocks
Nektar Therapeutics (NKTR) EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | -394.3 | -463.0 | -325.5 | -323.9 | -243.1 | -137.8 | |
| Changes by years, y/y, % | +3% | +17% | -30% | 0% | -25% | |||
Nektar Therapeutics. EBITDA US GAAP, bln rub
Nektar Therapeutics. EBITDA US GAAP, changes, %
Nektar Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Nektar Therapeutics (NKTR) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -38.3 | -33.6 | -29.7 | -44.5 | -30.0 | -137.8 | |
| Changes by years, y/y, % | +17% | -11% | -10% | +56% | -22% | |||
| Changes by quarters, q/q, % | +35% | -12% | -12% | +50% | -32% | |||
